| API | Active pharmaceutical ingredient |
| RES | Reticuloendothelial system |
| NLCs | Nanostructured lipid carriers |
| GRAS | Generally recognized as safe |
| TEs | Transethosomes |
| SC | Stratum corneum |
| HA | Novel hyaluronic acid |
| 5-FU | 5-Fluorouracil |
| HA-GMS-T | Hyaluronic acid–glycerol monostearate–transfersome |
| MTO | Mitoxantrone |
| PEG | Polyethylene glycol |
| MIC | Minimum inhibitory concentration |
| ECN | Econazole nitrate |
| EVs | Elastic vesicles |
| VICCO | Vishnu Industrial Chemical Company |
| GIT | Gastrointestinal tract |
| SH | Sinomenine hydrochloride |
| NE | Non-ethosomal |
| HIV | Human immunodeficiency virus |
| HA–PG–ES | Hyaluronic-acid-coupled propylene-glycol-based ethosome |
| SLN | Solid lipid nanoparticles |
| PDT | Photodynamic therapy |
| SCC | Squamous-cell carcinoma |